Wilson’s Disease. Onset and Complex Diagnosis: Clinical Case
https://doi.org/10.15690/vsp.v23i6.2834
Abstract
Background. The low prevalence of Wilson’s disease, diversity of clinical signs, long latent course, inheritance features make it difficult to diagnose and require multidisciplinary approach from doctors. Clinical case description. This article describes a clinical case of Wilson’s disease, rare hereditary multisystem disease, diagnosed in patient F., 13 years old. The disease onset was at the age of 6 masked by gastroesophageal reflux disease. Hepatomegaly, cytolysis, and cholestasis were diagnosed 4 years later, thus diagnosis of hepatitis of unknown origin was established requiring further specification. The decrease of free copper level in serum was revealed at the age of 12, penicillamine test was positive. Molecular genetic testing was performed and the pathogenic variant c.3207C>A (heterozygous state) in the ATP7B gene was revealed. We have measured 4 points via the Leipzig score for Wilson’s disease (Leipzig, 2001): serum ceruloplasmin <20 mg/dL — 1 point, increase in urinary copper excretion of more than 5 times at penicillamine test — 2 points, pathogenic variant c.3207C>A (heterozygous state) in the gene ATP7B — 1 point. This score corresponds to the diagnosis of Wilson’s disease. The use of chelation and hepatoprotective therapy has led to positive dynamics. Thus, the disease can debut with nonspecific, asymptomatic increases in transaminases and ultrasound changes in liver at any age. Wilson’s disease is progressive disease and in the absence of timely initiated therapy, patients die due to complications of cirrhosis and/or (less often) progressive neurological symptoms. The prognosis can be favorable with effective chelation therapy or liver transplantation. Conclusion. The described clinical case demonstrates the variability of clinical signs in children with Wilson’s disease that complicates the diagnostic search and early diagnosis
About the Authors
Elena S. ZasteloRussian Federation
Nizhny Novgorod
Disclosure of interest:
Not specified.
Elvira N. Fedulova
Russian Federation
Nizhny Novgorod
Disclosure of interest:
Not specified.
Anastasiya N. Gabrikevich
Russian Federation
Nizhny Novgorod
Disclosure of interest:
Not specified.
Tatiana V. Skochilova
Russian Federation
Nizhny Novgorod
Disclosure of interest:
Not specified.
Anatoly I. Khavkin
Russian Federation
Moscow
Disclosure of interest:
Not specified.
References
1. Narusheniya obmena medi (bolezn’ Vil’sona – Konovalova): Clinical guidelines. Union of Pediatricians of Russia, Association of Medical Geneticists. Ministry of Health of Russian Federation; 2021. 55 p. (In Russ).] Доступно по: https://www.pediatr-russia.ru/information/klin-rek/proekty-klinicheskikh-rekomendatsiy/%D0%91%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C%20%D0%92%D0%B8%D0%BB%D1%8C%D1%81%D0%BE%D0%BD%D0%B0%20%20_01.06.2021.pdf. Ссылка активна на 28.11.2024.
2. Wilson disease. In: Orphanet: Official website. Available online: https://www.orpha.net/en/disease/detail/905?search=Disorder-of-copper-metabolism&mode=name. Accessed on November 28, 2023).
3. Atlas redkikh boleznei. Baranov AA, Namazova-Baranova LS, eds. 2nd edn., rev. and add. Moscow: Pediatr; 2016. 420 p. (In Russ).
4. Baiazutdinova GM, Shchagina OA, Poliakov AV. The study of common mutation p.H1069Q in АТР7В gene in Russian WD-patients. Medical Genetics. 2018;17(4):25–30. (In Russ). doi: https://doi.org/10.25557/2073-7998.2018.04.25-30
5. Krasil’nikova EYu, Sokolov AA. Analiz situatsii v sfere okazaniya meditsinskoi pomoshchi i lekarstvennogo obespecheniya patsientov, stradayushchikh redkimi zabolevaniyami, v period 2013–2015 godov. Health Care Standardization Problems. 2016;(3-4):42–51. (In Russ).]
6. Samodova OV, Smirnova GP, Krieger EA. Wilson – Konovalov Disease: Clinical Cases with Different Manifestations and Outcomes. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(1):77–83. (In Russ). doi: https://doi.org/10.22416/1382-4376-2023-33-1-77-83
7. Komarova AD, Potapov AS, Savostyanov KV, et al. Challenges in the diagnosis of Wilson’s disease in young children. Voprosy detskoi dietologii = Pediatric Nutrition. 2024;22(2):13–21. (In Russ). doi: https://doi.org/10.20953/1727-5784-2024-2-13-21
8. Gerner EA, Nazarov VD, Fedorova TF, et al. Clinical, laboratory and molecular genetic diagnosis of Wilson – Konovalov disease. Russian Neurological Journal. 2019;24(3):10–18. (In Russ). doi: https://doi.org/10.30629/2658-7947-2019-24-3-10-18
9. Ivleva SA, Dvoryakovskaya GM, Chetkina TS, et al. Detection of stages of liver fibrosis in children with Wilson’s disease. Russian Pediatric Journal. 2014;17(3):9–16. (In Russ).]
10. Reizis AR. Wilson – Konovalov disease in children. Doctor.Ru. 2020;19(10): 52–56. (In Russ). doi: https://doi.org/10.31550/1727-2378-2020-19-10-52-56
11. Gerosa C, Fanni D, Congiu T, et al. Liver pathology in Wilson’s disease: From copper overload to cirrhosis. J Inorg Biochem. 2019;193:106–111. doi: https://doi.org/10.1016/j.jinorgbio.2019.01.008
12. Murillo O, Luqui DM, Gazquez C, et al. Long-term metabolic correction of Wilson’s disease in a murine model by gene therapy. J Hepatol. 2016;64(2):419–426. doi: https://doi.org/10.1016/j.jhep.2015.09.014
13. Lucena-Valera A, Perez-Palacios D, Muñoz-Hernandez R, et al. Wilson’s disease: Revisiting an old friend. World J Hepatol. 2021;13(6):634. doi: https://doi.org/10.4254%2Fwjh.v13.i6.634
14. Hermann W. Classification and differential diagnosis of Wilson’s disease. Ann Transl Med. 2019;7(Suppl 2):S63. doi: https://doi.org/10.21037/atm.2019.02.07
15. Konovalov NV. Gepatolentikulyarnaya distrofiya. Moscow; 1960. 556 p. (In Russ).]
16. Azizi E, Eshel G, Aladjem M. Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr. 1989;148(6): 548–549. doi: https://doi.org/10.1007/BF00441555
17. Golding DN, Walshe JM. Arthropathy of Wilson’s disease. Study of clinical and radiological features in 32 patients. Ann Rheum Dis. 1977;36(2):99–111. doi: https://doi.org/10.1136/ard.36.2.99
18. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23(3):139–142. doi: https://doi.org/10.1034/j.1600-0676.2003.00824.x
19. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson’s disease: clinical presentation and use of prognostic index. Gut. 1986;27(11): 1377–1381. doi: https://doi.org/10.1136/gut.27.11.1377
20. Saroli Palumbo C, Schilsky ML. Clinical practice guidelines in Wilson disease. Ann Transl Med. 2019;7(Suppl 2):S65. doi: https://doi.org/10.21037/atm.2018.12.53
21. Socha P, Janczyk W, Dhawan A, et al. Wilson’s Disease in Children: A Position Paper by the Hepatology Committee of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(2):334–344. d oi: https://doi.org/10.1097/MPG.0000000000001787
22. Czlonkowska A, Gajda J, Rodo M, et al. Effects of long-term treatment in Wilson’s disease with D-penicillamine and zinc sulphate. J Neurol. 1996;243(3):269–273. doi: https://doi.org/10.1007/bf00868525
23. Weiss KH, Thurik F, Gotthardt DN, et al. Efficacy and safety of oral chelators in treatment of patients with Wilson disease. Clin Gastroenterol Hepatol. 2013;11(8):1028–1035.e1–e2. doi: https://doi.org/10.1016/j.cgh.2013.03.012
24. Ahmad A, Torrazza-Perez E, Schilsky ML. Liver transplantation for Wilson disease. Handb Clin Neurol. 2017:142:193–204. d oi: https://doi.org/10.1016/B978-0-444-63625-6.00016-1
Review
For citations:
Zastelo E.S., Fedulova E.N., Gabrikevich A.N., Skochilova T.V., Khavkin A.I. Wilson’s Disease. Onset and Complex Diagnosis: Clinical Case. Current Pediatrics. 2024;23(6):483-488. (In Russ.) https://doi.org/10.15690/vsp.v23i6.2834